NCR3LG1 and viral infectious disease: The activating NKG2D ligands and B7-H6 (NKp30 ligand), which are typically upregulated in response to viral infection or in cancer cells [26,80], were not upregulated during VACV infection and this may represent a novel strategy by which VACV evades the NK cell response.